American Banker reports: The House Financial Services Committee is threatening to file contempt charges against Consumer Financial Protection Bureau Director Richard Cordray for allegedly lying about the bureau's investigation into the Wells Fargo scandal. In a 15-page report released Tuesday by Republican staff, the committee claimed that the CFPB has not produced records showing that […]
Category Archives: Uncategorized
The Consumer Financial Protection Bureau explains in this blog post.
That's the name of this article by Nelson Schwartz. It describes the concierge doctors and high-frills medical care available, without significant wait times, to very wealthy people willing to pay steep prices. It contrasts that with what the non-rich get. (For instance, wait times for doctor appointments have been going up in recent years in most places.)
That's the topic of Fighting Fines & Fees: Borrowing from Consumer Law to Combat Criminal Justice Debt Abuses by law prof Neil Sobol. Here is the abstract: Although media and academic sources often describe mass incarceration as the primary challenge facing the American criminal justice system, the imposition of criminal justice debt may be a more pervasive […]
The OCC regulates national banks and has some power over consumer protection issues. The Financial Times has the story here. Excerpt: If confirmed by the Senate, Mr Otting is likely to be “a reliable ally” for Mr Mnuchin and “a steady proponent for bank deregulation”, said Isaac Boltansky, analyst at Compass Point in Washington.
The Federal Trade Commission announced today that, in a case filed by it and the Florida Office of the Attorney General, a federal district court judge has entered eight orders against an intertwined web of Orlando-based individuals and companies that bombarded consumers with illegal robocalls from “Card Member Services,” pitching worthless credit card interest rate […]
Politico reports today that the Department of Education is considering delaying two rules that are scheduled to go into effect on July 1 — the borrower defense rule, which concerns student loans, and the gainful employment rules, which cuts off federal funding for for-profit colleges that provide students with more debt than benefit. The article […]
The headline is Outcry Over EpiPen Prices Hasn’t Made Them Lower. Excerpt: By August, the company, which sells thousands of drugs and says it fills one in every 13 American prescriptions, was making mea culpas and renewing its promise to “do what’s right, not what’s easy,” as the company’s mission statement goes. * * * […]
A company called Magellan Diagnostics touts itself as "the most trusted name in lead testing." But the Food and Drug Administration disagrees, saying that many of the company's products are inaccurate. The problem may go all the way back to 2014. And the problem appears to be false negatives — some of the company's lead […]
The Washington Post has this article.